v3.24.2.u1
STOCK-BASED COMPENSATION (Tables)
 3 Months Ended
Mar. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF OPTIONS OUTSTANDING AND EXERCISABLE

 

   As of March 31, 2024 
   Aggregate Intrinsic Value   Weighted - Average Remaining Contractual Life in Years 
Options outstanding  $1,780    6.86 
Options exercisable  $604    5.95 
SCHEDULE OF FAIR VALUE STOCK OPTION ASSUMPTIONS

The fair value of each option grant on the date of grant is estimated using the Black-Scholes option-pricing model reflecting the following weighted-average assumptions:

 

   December 31, 2021   December 31, 2022   December 31, 2023 
Expected volatility   50.2%   49.4%   55.6%
Expected life of options   6.5 years    6.5 years    6.1 years 
Risk free interest rate   0.69%   1.73%   3.87%
Dividend yield   0%   0%   0%
Weighted-average fair value of options granted during the year  $3.81   $2.04   $1.66 
Stock Options Including Market Based Stock [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF STOCK OPTIONS ACTIVITY

A summary of the status of the Company’s stock options, relating to the Company’s market-based stock options that were granted to certain senior managers, including the Company’s executive officers, as of December 31, 2021, 2022 and 2023 and March 31, 2024, and changes during the periods then ended is presented below:

 

   December 31, 2021   December 31, 2022   December 31, 2023   March 31, 2024 
   Number of Shares   Weighted-
Average
Exercise Price		   Number of Shares   Weighted-
Average
Exercise Price		   Number of Shares   Weighted-
Average
Exercise Price		   Number of Shares   Weighted-
Average
Exercise Price		 
Outstanding at beginning of period   -   $-    -   $-    5,065   $14.14    5,445   $13.39 
Granted   -   $-    5,065   $14.14    865   $3.09    -   $- 
Exercised   -   $-    -   $-    -   $-    -   $- 
Forfeited or expired   -   $-    -   $-    (485)  $2.87    -   $- 
                                                        
Outstanding at end of period   -   $-    5,065   $14.14    5,445   $13.39    5,445   $13.39 
                                        
Exercisable at end of period   -   $-    -   $-    -   $-    -   $- 
SUMMARY OF STOCK OPTION INFORMATION BY EXERCISE PRICE RANGE

The following table summarizes information about stock options relating to the market-based stock options that were granted to certain senior managers, including the Company’s executive officers, at March 31, 2024.

 

    Options Outstanding   Options Exercisable 
Exercise Prices ($)   Number Outstanding   Weighted - Average Remaining Contractual Life in Years   Weighted Average Exercise Price   Number Outstanding   Weighted - Average Exercise Price 
$2.98 - $7.48    1,320    8.62   $3.18           -   $     - 
$7.49 - $11.98    875    7.70   $10.50    -   $- 
$11.99 - $16.48    1,250    7.76   $14.00    -   $- 
$16.49 - $21.00    2,000    7.76   $21.00    -   $- 
      5,445    7.97   $13.38    -   $- 
Stock Options Excluding Market Based Stock [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF STOCK OPTIONS ACTIVITY

A summary of the status of the Company’s stock options, excluding the market-based stock options that were granted to certain senior managers, including the Company’s executive officers, as of December 31, 2021, 2022 and 2023 and March 31, 2024 and changes during the periods then ended, is presented below:

 

   December 31, 2021   December 31, 2022   December 31, 2023   March 31, 2024 
   Number of Shares   Weighted-
Average
Exercise Price		   Number of Shares   Weighted-
Average
Exercise Price		   Number of Shares   Weighted-
Average
Exercise Price		   Number of Shares   Weighted-
Average
Exercise Price		 
Outstanding at beginning of period   3,624   $5.85    3,470   $5.91    2,727   $5.29    2,192   $4.79 
Granted   120   $7.77    895   $4.08    470   $3.09    -   $- 
Exercised   (156)  $5.60    -   $-    (16)  $2.33    -   $- 
Forfeited or expired   (118)  $6.34    (1,638)  $5.95    (989)  $5.40    (214)  $5.81 
                                         
Outstanding at end of period   3,470   $5.91    2,727   $5.29    2,192   $4.79    1,978   $4.68 
                                         
Exercisable at end of period   1,546   $5.67    1,247   $5.79    1,189   $5.54    1,232   $5.21 
SUMMARY OF STOCK OPTION INFORMATION BY EXERCISE PRICE RANGE

 

    Options Outstanding   Options Exercisable 
Exercise Prices ($)   Number Outstanding   Weighted - Average Remaining Contractual Life in Years   Weighted Average Exercise Price   Number Outstanding   Weighted - Average Exercise Price 
$2.98 - $4.23    690    8.65   $3.18    214   $3.23 
$4.24 - $5.48    568    7.30   $4.83    313   $4.87 
$5.49 - $6.73    690    4.71   $5.91    683   $5.91 
$6.74- $7.96    30    6.87   $7.82    22   $7.82 
      1,978    6.86   $4.68    1,232   $5.21 
Restricted Stock [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

  

Number of

Non-Vested Shares

   Weighted- Average
Grant Date Fair Value		 
Non-vested, January 1, 2021   806   $5.54 
Granted   450    7.63 
Vested   (537)   5.35 
Forfeited or expired   (90)   6.51 
Non-vested, December 31, 2021   629    7.06 
Granted   492    3.72 
Vested   (229)   6.99 
Forfeited or expired   (186)   7.08 
Non-vested, December 31, 2022   706    4.75 
Granted   1,247    2.41 
Vested   (297)   4.24 
Forfeited or expired   (152)   5.32 
Non-vested, December 31, 2023   1,504    2.86 
Granted   -    - 
Vested   (128)   4.51 
Forfeited or expired   (6)   7.22 
Non-vested, March 31, 2024   1,370   $2.68